Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo

Abstract Background The blocking of the programmed cell death protein (PD-1)/programmed death-ligand 1 (PD-L1) axis has been found to have an anticancer activity against various types of cancer by enhancing T cell immunity, while there are no studies linking the PD-1/PD-L1 axis to chemotherapy drugs...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiaoqiang Liu, Shaoya He, Huaming Wu, Hui Xie, Tao Zhang, Zhongliang Deng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Komiyama Printing Co. Ltd 2019-12-01
coleção:	Environmental Health and Preventive Medicine
Assuntos:	Osteosarcoma PD-L1 Cisplatin Anti-PD-1 antibody Treg cell
Acesso em linha:	https://doi.org/10.1186/s12199-019-0835-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!